Hematology/Oncology

Investigators are developing diagnostic markers and radioisotopes that may be used for the diagnosis and management of metastatic bone cancer, breast cancer, prostate cancer, and other types of cancer.

Research conducted by VA investigators aims to design prostate and breast cancer radio therapeutic treatments by using conventional chemotherapy to enhance targeted radiotherapy as a means to achieve better outcomes and fewer/decreased side effects

Clinical Trials

Clinical trials help determine the best standard of care (which treatment is better) and better ways to diagnose, treat and prevent cancer.

The clinical trials in which the Truman VA chooses to participate look at cancer therapies in organized, detailed ways. Clinical trials are the only way to find out what new approaches to prevention, screening, treatment and survival work better than existing ones.

The Truman VA is an affiliate member (under the University of Missouri) to the Alliance and Alliance Foundation group.

The Alliance for Clinical Trials in Oncology develops and conducts clinical trials with promising new cancer therapies, and utilizes the best science to develop optimal treatment and prevention strategies for cancer, as well as researches methods to alleviate side effects of cancer and cancer treatments.